Therapist Jo Dice discusses some key points that you may want to know before taking psychedelics.
Canada’s non-profit advocacy organisation TheraPsil has announced the launch of its MDMA-assisted psychotherapy training programme.
ADHD seems to be the diagnosis du jour nowadays.
In the face of escalating climate, economic and mental health crises, millions are seeking legal, safe ways to experience magic mushrooms (psilocybin) and other psychoactive plant...
California could decriminalise naturally occurring psychedelics and create a framework for their therapeutic use under a new bill.
Ketamine has been an FDA-approved medical anaesthetic since 1970, and in the early 2000s a ground-breaking discovery was made about the antidepressant effects of ketamine.
A new research review has explored the use of psilocybin for the treatment of resistant depression.
In a new policy briefing for the European Medicines Agency (EMA), Psychedelic Access and Research European Alliance (PAREA) has called for an advisory body on psychedelics...
In the latest development for psychedelics in the UK, the Home Affairs Committee Drug Report has seen MPs call for a review of drug scheduling in...
Launching in 2008 as a drug literature review blog by Rob Dickins, Psychedelic Press has brought readers a host of unique insights into psychedelic thought and...